Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (25)

2022

  1. A Score to Assess Mortality After Percutaneous Mitral Valve Repair

    Journal of the American College of Cardiology, Vol. 79, Núm. 6, pp. 562-573

  2. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  3. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396

  4. Prognostic Impact of Nutritional Status After Transcatheter Edge-to-Edge Mitral Valve Repair: The MIVNUT Registry

    Journal of the American Heart Association, Vol. 11, Núm. 20

2020

  1. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial

    EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921

  2. Major bleeding predictors in patients with left atrial appendage closure: The iberian registry ii

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11

2019

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study

    EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252

  2. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II

    Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 449-455

  3. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70

  4. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

    Circulation, Vol. 140, Núm. 23, pp. 1904-1916

  5. Trends and Bibliometric Impact of Research Grants of the Spanish Society of Cardiology/Spanish Heart Foundation (2007-2012)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1012-1019

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Criteria for the Management of Technological Assets in Cardiovascular Imaging

    Revista Espanola de Cardiologia, Vol. 71, Núm. 8, pp. 643-655

2017

  1. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486

  2. Outcomes and predictors of success and complications for paravalvular leak closure: An analysis of the Spanish realwOrld paravalvular LEaks closure (HOLE) registry

    EuroIntervention, Vol. 12, Núm. 16, pp. 1962-1968

2016

  1. Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)

    American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554

  2. Quality Improvement Strategy of the Spanish Society of Cardiology: The RECALCAR Registry

    Journal of the American College of Cardiology

  3. Tipología y estándares de calidad de las unidades de insuficiencia cardiaca: consenso científico de la Sociedad Española de Cardiología

    Revista Espanola de Cardiologia, Vol. 69, Núm. 10, pp. 940-950

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386